News
New report on services in Scotland.
A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
In August 2018, Kyle Alexander was appointed by co-option to the Board of Trustees, bringing a Northern Ireland presence to the board.
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
The government have announced a relaxation of the laws governing access to cannabis-based medicines. This will give doctors the ability to prescribe them.